Vitamin E significantly improves liver health in MASH patients, new study finds

New research shows that Vitamin E therapy significantly enhances liver function and reduces inflammation in MASH patients, providing a safer and effective treatment option in the fight against metabolic liver disease. Study: Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study In a recent study published in the journal Cell Reports … Read more

Globally prostate and testicular cancer rates climb, but mortality is falling

A global study on prostate and testicular cancers reveals rising prevalence and incidence but declining mortality, highlighting the need for targeted healthcare strategies. Study: Global burden and risk factors of male cancers from 1990 to 2021, with forecasts to 2040. Image Credit: Julien Tromeur / Shutterstock Prostate and testicular cancers are growing concerns for men’s health worldwide. … Read more

Engineered fat cells starve tumors and prevent cancer growth

Scientists transformed energy-storing white fat cells into calorie-burning ‘beige’ fat. Once implanted, they outcompeted tumors for resources, beating back five different types of cancer in lab experiments. Liposuction and plastic surgery aren’t often mentioned in the same breath as cancer.  But they are the inspiration for a new approach to treating cancer that uses engineered … Read more

Developmental epigenetic changes could shape cancer risk later in life

A person’s lifetime risk for cancer may begin before they are even born, reports a paradigm-shifting study by Van Andel Institute scientists. The findings, published in Nature Cancer, identified two distinct epigenetic states that arise during development and are linked to cancer risk. One of these states is associated with a lower lifetime risk while … Read more

Exploring the use of genomic classifier tests in prostate cancer risk stratification

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for better data on their cost-effectiveness, clinical utility, and their impact on racial and ethnic groups, particularly Black men. The study is published in Annals of Internal … Read more

Expert consensus provides unified framework for prostate cancer care in China

While prostate cancer is becoming more prevalent among middle-aged and elderly men in China, clinical practice still faces considerable challenges due to the lack of unified guidelines and high-level evidence on several aspects of patient care. Despite the publication of various international and domestic guidelines, many crucial areas remain unclear, particularly in the management of … Read more